skip to content
Asymptomatic atherosclerosis : pathophysiology, detection, and treatment Preview this item
ClosePreview this item

Asymptomatic atherosclerosis : pathophysiology, detection, and treatment

Author: Morteza Naghavi
Publisher: [New York] : Humana Press, ©2010.
Series: Contemporary cardiology (Totowa, N.J.)
Edition/Format:   eBook : Document : EnglishView all editions and formats
Despite recent advances in the diagnosis and treatment of symptomatic atherosclerosis, available traditional screening methods for early detection and treatment of asymptomatic coronary artery disease are grossly insufficient and fail to identify the majority of victims prior to the onset of a life-threatening event. In Asymptomatic Atherosclerosis: Pathophysiology, Detection and Treatment, Dr. Morteza Naghavi and  Read more...

(not yet rated) 0 with reviews - Be the first.

More like this


Find a copy online

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...


Genre/Form: Electronic books
Additional Physical Format: Print version:
Asymptomatic atherosclerosis.
[New York] : Humana Press, ©2010
(DLC) 2009930357
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Morteza Naghavi
ISBN: 9781603271790 1603271791
OCLC Number: 663096542
Description: 1 online resource (xxii, 737 pages) : illustrations (some color), portraits.
Contents: 1. Preventive Cardiology: The SHAPE of the Future.- 2. From Vulnerable Plaque to Vulnerable Patient.- 3. Pathology of Vulnerability Caused by High Risk (Vulnerable) Arteries and Plaques.- 4. Pathophysiology of Vulnerability Caused by Thrombogenic (Vulnerable) Blood.- 5. Vulnerability Caused by Arrhythmogenic Vulnerable Myocardium.- 6. Approach to the Identification of the Vulnerable Patient.- Current Screening Guidelines in Primary Prevention.- Burden of Atherosclerotic Cardiovascular Disease. Risk Factors vs Susceptibility vs Vulnerability. Screening for Silent Disease to Prevent Deadly Disease. Screening for Atherosclerosis vs Screening for Risk Factors of Atherosclerosis. Methods for the Detection of Subclinical Atherosclerotic Cardiovascular Disease.- Risk Factors: 7. History of evolution of cardiovascular risk factors and the predictive value of Traditional Risk Factor-Based Risk Assessment.- 8. Comprehensive Lipid Profiling Beyond LDL.- 9. New Serum Markers of Inflammation and Atherosclerosis.- 10. Genetic Screening and Sudden Cardiac Death.- 11. Genomics and Proteomics: The Role of Contemporary Biomolecular Analysis.- In Advancing the Knowledge of Atherosclerotic Coronary Artery Disease.- 12. Circulating Endothelial Progenitor Cells - Mechanism and Measurements.- 13. Family History: An index of genetic and environmental predisposition to coronary artery disease.- 14. Integration of Markers of Endothelial Activation in Mechanism-based Management of Coronary Artery Disease.- Non Invasive, Non Imaging, Assessment of Atherosclerotic Cardiovascular Disease (ACVD)15. Exercise stress testing in asymptomatic individuals and its relation to subclinical atherosclerotic cardiovascular disease16. The Ankle Brachial Index17. Arterial Elasticity/Stiffness18. Assessment of Endothelial Function in Clinical Practice 19. Digital (Fingertip) Thermal Monitoring of Vascular Function: A Novel Non-invasive Non-imaging Test to Improve Traditional Cardiovascular Risk Assessment and Monitoring of Response to Treatments 20. Assessment of Macro & Micro Vascular Function and Reactivity Non Invasive Structural Imaging of Subclinical ACVD21. Computed Tomographic Angiography 22. Carotid Intima-Media Thickness 23. Carotid intima-media thickness: clinical implementation in individual cardiovascular risk assessment 24. Non-Invasive Coronary CT Angiography25. Non-Invasive CT v.s. MRI for Characterization of Atherosclerosis Plaque26. Non-Invasive Magnetic Resonance Imaging of Aorta and Coronary Arteries27. The Role of MRI in Examining Subclinical Carotid PlaqueNon Invasive Functional Imaging of Subclinical ACVD28. Ultrasound Imaging of Brachial Artery Reactivity (FMD)29. Silent and Stress-Induced Myocardial Ischemia30. Targeted MRI of Molecular Components in Atherosclerotic Plaque 31. Non Invasive imaging of vulnerable myocardium- MRI and CT basedInvasive Assessment of ACVD32. Angiographic Detection of Complex and Vulnerable Atherosclerotic Plaques33. Intravascular Methods for Characterizing Potentially High Risk Coronary Plaques. 34. Detecting Vulnerable Plaque Using Invasive Methods35. Assessment of Plaque Burden and Composition using Intravascular Ultrasound36. Vasa Vasorum Imaging: A New Window to the Detection of Vulnerable Atherosclerotic Plaques37. The First SHAPE Guideline; 38. Cost-Effectiveness of Screening for Atherosclerosis vs. Screening for Risk Factors of Atherosclerosis39. Monitoring of Subclinical Atherosclerotic Disease40. Implications of SHAPE Guideline for Improving Patient Compliance41. The Cost-Conscious SHAPE Guideline - Why Primary Care Physicians Should Embrace It42. Should we treat based on SHAPE guidelines??43. Duty-Bound: Philosophical Foundations of Clinical Strategies for Prevention of Cardiovascular Events44. Dynamic Changes in Risk as the Basis for Therapeutic TriageTreatment of Subclinical ACVD and Vulnerable Patients Systemic Therapies45. LDL Targeted Therapies46. Antioxidants as targeted therapy: a special protective role for pomegranate and paraoxonases (PONs)47. Multi-Constituent Cardiovascular Pills (MCCP) - Challenges and Promises of Population Based Prophylactic Drug Therapy for Prevention of Heart Attack48. Vaccine for Atherosclerosis: An Emerging New Paradigm Focal Therapies for Vulnerable Arteries and Plaques49. Drug Eluting Stents: A Potential Preemptive Treatment Choice for Vulnerable Coronary Plaques50. Intrapericardial Approach for Pan Coronary Stabilization of the Vulnerable Arteries and MyocardiumEducations, Life Style Modifications and Non-pharmacologic Therapies for the Atherosclerosis Susceptible and ACVD Vulnerable Population51. Dietary Management for Coronary Atherosclerosis Prevention & Treatment52. Management of Preconditioning Physical Activity in a Vulnerable Patient; Getting in SHAPE53. Acute Prevention of the Heart Attack: the Identification of Prodromal Symptom Recognition as the "Rosetta Stone" in Solving the Heart Attack Problem
Series Title: Contemporary cardiology (Totowa, N.J.)
Responsibility: edited by Morteza Naghavi.


Here is a new paradigm for the screening and primary prevention of asymptomatic atherosclerosis. Includes the authors' comprehensive approach to identifying vulnerable patients, and new strategies  Read more...


Editorial reviews

Publisher Synopsis

From the reviews:"This book explores the latest developments in a multipronged preventive strategy to detect and treat asymptomatic patients at risk for future cardiovascular events based on severity Read more...

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...


Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data

Primary Entity

<> # Asymptomatic atherosclerosis : pathophysiology, detection, and treatment
    a schema:MediaObject, schema:Book, schema:CreativeWork ;
   library:oclcnum "663096542" ;
   library:placeOfPublication <> ; # New York
   library:placeOfPublication <> ;
   schema:about <> ; # Internal medicine
   schema:about <> ; # Family medicine
   schema:about <> ;
   schema:about <> ; # Cardiology
   schema:about <> ; # Atherosclerosis--therapy
   schema:about <> ; # Médecine
   schema:about <> ; # Atherosclerosis--physiopathology
   schema:about <> ; # Arteriosclerosis--Treatment
   schema:about <> ; # Arteriosclerosis--Diagnosis
   schema:about <> ; # Atherosclerosis--diagnosis
   schema:about <> ; # Medicine
   schema:about <> ; # Emergency medicine
   schema:about <> ; # Atherosclerosis
   schema:about <> ; # MEDICAL--Cardiology
   schema:bookFormat schema:EBook ;
   schema:contributor <> ; # Morteza Naghavi
   schema:copyrightYear "2010" ;
   schema:datePublished "2010" ;
   schema:description "Despite recent advances in the diagnosis and treatment of symptomatic atherosclerosis, available traditional screening methods for early detection and treatment of asymptomatic coronary artery disease are grossly insufficient and fail to identify the majority of victims prior to the onset of a life-threatening event. In Asymptomatic Atherosclerosis: Pathophysiology, Detection and Treatment, Dr. Morteza Naghavi and leading authorities from the Society for Heart Attack Prevention and Eradication (SHAPE) present a new paradigm for the screening and primary prevention of asymptomatic atherosclerosis. The text focuses on accurate, yet underutilized, measures of subclinical atherosclerosis, notably coronary artery calcium scanning and carotid intima-media thickness measurement. The authors introduce a comprehensive approach to identifying the vulnerable patients (asymptomatic individuals at risk of a near future adverse event). Additional chapters discuss future directions towards containing the epidemic of atherosclerotic cardiovascular disease using innovative solutions such as preemptive interventional therapies (bioabsorbable stents) for stabilization of vulnerable atherosclerotic plaques, mass unconditional Polypill therapy for population-based risk reduction, and ultimately vaccination strategies to prevent the development of atherosclerosis. Up-to-date and authoritative, Asymptomatic Atherosclerosis: Pathophysiology, Detection, and Treatment is a must-have for any cardiologist or primary care physician who wishes to practice modern preventive cardiology and manage the increasing number of asymptomatic atherosclerotic patients. Outlines more accurate measures of risk (coronary artery calcium and carotid intima-media thickness) than traditional risk factors (total cholesterol, LDL cholesterol, HDL cholesterol) Presents new multipronged strategies to aid in the early detection and treatment of high risk asymptomatic patients."@en ;
   schema:exampleOfWork <> ;
   schema:genre "Electronic books"@en ;
   schema:inLanguage "en" ;
   schema:isPartOf <> ; # Contemporary cardiology
   schema:isPartOf <> ; # Contemporary cardiology (Totowa, N.J.)
   schema:isSimilarTo <> ;
   schema:name "Asymptomatic atherosclerosis : pathophysiology, detection, and treatment"@en ;
   schema:productID "663096542" ;
   schema:publication <> ;
   schema:publisher <> ; # Humana Press
   schema:url <> ;
   schema:url <> ;
   schema:url <> ;
   schema:url <> ;
   schema:url <> ;
   schema:url <> ;
   schema:url <> ;
   schema:url <> ;
   schema:workExample <> ;
   schema:workExample <> ;
   umbel:isLike <> ;
   wdrs:describedby <> ;

Related Entities

<> # New York
    a schema:Place ;
   schema:name "New York" ;

<> # Contemporary cardiology
    a bgn:PublicationSeries ;
   schema:hasPart <> ; # Asymptomatic atherosclerosis : pathophysiology, detection, and treatment
   schema:name "Contemporary cardiology" ;

<> # Contemporary cardiology (Totowa, N.J.)
    a bgn:PublicationSeries ;
   schema:hasPart <> ; # Asymptomatic atherosclerosis : pathophysiology, detection, and treatment
   schema:name "Contemporary cardiology (Totowa, N.J.)" ;

<> # Atherosclerosis--diagnosis
    a schema:Intangible ;
   schema:name "Atherosclerosis--diagnosis"@en ;

<> # Atherosclerosis--physiopathology
    a schema:Intangible ;
   schema:name "Atherosclerosis--physiopathology"@en ;

<> # Atherosclerosis--therapy
    a schema:Intangible ;
   schema:name "Atherosclerosis--therapy"@en ;

<> # MEDICAL--Cardiology
    a schema:Intangible ;
   schema:name "MEDICAL--Cardiology"@en ;

<> # Atherosclerosis
    a schema:Intangible ;
   schema:name "Atherosclerosis"@en ;

<> # Medicine
    a schema:Intangible ;
   schema:name "Medicine"@en ;

<> # Cardiology
    a schema:Intangible ;
   schema:name "Cardiology"@en ;

<> # Emergency medicine
    a schema:Intangible ;
   schema:name "Emergency medicine"@en ;

<> # Family medicine
    a schema:Intangible ;
   schema:name "Family medicine"@en ;

<> # Internal medicine
    a schema:Intangible ;
   schema:name "Internal medicine"@en ;

<> # Morteza Naghavi
    a schema:Person ;
   schema:familyName "Naghavi" ;
   schema:givenName "Morteza" ;
   schema:name "Morteza Naghavi" ;

    a schema:ProductModel ;
   schema:isbn "1603271791" ;
   schema:isbn "9781603271790" ;

    a schema:CreativeWork ;
   rdfs:label "Asymptomatic atherosclerosis." ;
   schema:description "Print version:" ;
   schema:isSimilarTo <> ; # Asymptomatic atherosclerosis : pathophysiology, detection, and treatment

Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.